Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics for Hysterosalpingography
NCT04234945Unknown
- Sponsor
- Ahmadu Bello University Teaching Hospital
- Start
- Jan 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of doxycycline in pelvic inflammatory disease (PID) (2 arms), sponsored by Ahmadu Bello University Teaching Hospital. Primary endpoints: Development of Fever, Clinical features of pelvic infection at 2 weeks and 1 more. Status: unknown.
02
Drugs
doxycycline
03
Conditions
pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT04234945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04234945.